Table 2.
Correlations between illness perception scales after diagnosis and HRQoL, anxiety and depression after 6, 12, and 24 months
Endometrial cancer | Ovarian cancer | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Illness perceptions after treatment | Symptoms experienced | Concerns | Emotional impact | Lower treatment trust | ||||||||
Months after treatment, outcome variables | 6 | 18 | 24 | 6 | 18 | 24 | 6 | 18 | 24 | 6 | 18 | 24 |
N | 158 | 147 | 128 | 158 | 147 | 128 | 158 | 147 | 128 | 124 | 101 | 75 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Global quality of life | − 0.24 | − 0.25* | − 0.21 | − 0.25* | − 0.29* | − 0.34* | − 0.29* | − 0.29* | − 0.29* | − 0.42* | − 0.40* | − 0.36* |
Function scales | ||||||||||||
Physical functioning | − 0.22 | − 0.19 | − 0.24 | − 0.14 | − 0.21 | − 0.19 | − 0.18 | − 0.22 | − 0.18 | − 0.24 | − 0.16 | − 0.16 |
Role functioning | − 0.06 | − 0.20 | − 0.28* | − 0.09 | − 0.15 | − 0.36* | − 0.22 | − 0.13 | − 0.25 | − 0.27 | − 0.18 | − 0.25 |
Emotional functioning | − 0.34* | − 0.21 | − 0.32* | − 0.32* | − 0.24 | − 0.38* | − 0.38* | − 0.29* | − 0.41* | − 0.28* | − 0.15 | − 0.27 |
Cognitive functioning | − 0.17 | − 0.07 | − 0.25 | − 0.14 | − 0.17 | − 0.28* | − 0.17 | − 0.06 | − 0.22 | − 0.19 | − 0.29 | − 0.34 |
Social functioning | − 0.41* | − 0.28* | − 0.32* | − 0.23 | − 0.29* | − 0.38* | − 0.33* | − 0.27* | − 0.27* | − 0.16 | − 0.07 | − 0.26 |
Symptom scales | ||||||||||||
Fatigue | 0.36* | 0.28* | 0.34* | 0.26 | 0.26 | 0.37 | 0.35* | 0.31* | 0.32* | 0.26 | 0.14 | 0.29 |
Nausea and vomiting | 0.13 | 0.21 | 0.24 | 0.06 | 0.05 | 0.14 | 0.15 | 0.09 | 0.12 | 0.14 | 0.15 | 0.33 |
Pain | 0.23 | 0.17 | 0.26 | 0.20 | 0.23 | 0.39* | 0.22 | 0.20 | 0.26 | 0.28* | 0.19 | 0.33 |
Dyspnea | 0.18 | 0.19 | 0.11 | 0.07 | 0.14 | 0.14 | 0.15 | 0.15 | 0.20 | 0.20 | 0.02 | 0.23 |
Insomnia | 0.32* | 0.17 | 0.25 | 0.23 | 0.19* | 0.28* | 0.30* | 0.22 | 0.26 | 0.31* | 0.20 | 0.18 |
Appetite loss | 0.28* | 0.16 | 0.23 | 0.18 | 0.03 | 0.28* | 0.27* | 0.14 | 0.24 | 0.22 | 0.09 | 0.44* |
Constipation | 0.04 | 0.03 | 0.09 | 0.11 | 0.02 | 0.22 | 0.14 | 0.08 | 0.22 | 0.21 | 0.21 | 0.14 |
Diarrhea | 0.18 | 0.11 | 0.13 | 0.15 | 0.11 | 0.05 | 0.21 | 0.08 | 0.14 | 0.06 | < 0.01 | 0.13 |
Financial difficulties | 0.30* | 0.20* | 0.20 | 0.17 | 0.08 | 0.11 | 0.21 | 0.10 | 0.08 | 0.16 | 0.09 | − 0.08 |
Anxiety | 0.30* | 0.33* | 0.34* | 0.41* | 0.45* | 0.46* | 0.46* | 0.47* | 0.45* | 0.39* | 0.31 | 0.24 |
Depression | 0.39* | 0.28* | 0.23* | 0.35* | 0.35* | 0.36* | 0.39* | 0.33* | 0.34* | 0.40* | 0.25 | 0.38* |
Pearson’s correlations were estimated between illness perceptions measured after diagnosis, and outcome variables after diagnosis and 6, 12, and 24 months after diagnosis. Only the illness perception items were included that have earlier been associated with trial allocation
*p < 0.003 (adjusted for Bonferroni correction 0.05/1)